FONAR Corp (FONR)
NASDAQHealth CareMedical - Equipment & ServicesSnapshot 2026-09-04
$19.090.00%
Close 2026-06-05 · 1-day change
NASDAQHealth CareMedical - Equipment & ServicesSnapshot 2026-09-04
Research Workspace
Put FONR beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Primary pillar under pressure — Manage new MRI center in Nassau County by end of Fiscal 2026: Merger closed 2026-06-03; delisting requested; entity no longer independent.
View ThesisRevenue is growing steadily — about 1% over the past year.
View GrowthManagement screens strong on capital allocation.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 0% on a typical day and fell roughly 14% in its worst 12-month stretch.
View RiskFONR's growth depends on managing the new MRI center in Nassau County by the end of Fiscal 2026. Recent financial performance remains strong, but it slipped notably this past month. The company trades at a premium compared to its sector peers, which raises concerns about sustaining this valuation. If FONR cuts guidance on the next call, that would negatively impact expectations. The thesis is on watch due to this primary pillar being under pressure. This read is provisional.
Trailing returns as of 2026-06-05. FONR is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Continue this research
Compare FONR with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| FONR Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Life Sciences Tools & Services — fair value, gap to price, and forward P/E.
Compare the value case
Put FONR next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-06-05. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.